CFMC
BEAT

Curbstone Financial Management Corp’s BioTelemetry, Inc. BEAT Stock Holding History

Curbstone Financial Management Corp’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,030
Closed -$1.8M – 188
2020
Q4 		$1.8M Buy
25,030
+300
+1% +$15.7K 0.38% 71
2020
Q3 		$1.13M Buy
24,730
+420
+2% +$17.6K 0.27% 93
2020
Q2 		$1.1M Buy
24,310
+250
+1% +$11.2K 0.28% 85
2020
Q1 		$927K Sell
24,060
-250
-1% -$11.5K 0.28% 88
2019
Q4 		$1.13M Buy
24,310
+850
+4% +$36.8K 0.27% 99
2019
Q3 		$956K Buy
23,460
+1,530
+7% +$66.1K 0.25% 103
2019
Q2 		$1.06M Sell
21,930
-1,700
-7% -$89.4K 0.28% 94
2019
Q1 		$1.48M Sell
23,630
-350
-1% -$24K 0.4% 69
2018
Q4 		$1.43M Sell
23,980
-200
-0.8% -$12K 0.43% 65
2018
Q3 		$1.56M Sell
24,180
-1,100
-4% -$61.4K 0.41% 69
2018
Q2 		$1.14M Hold
25,280
– – 0.31% 86
2018
Q1 		$785K Buy
25,280
+13,065
+107% +$430K 0.22% 123
2017
Q4 		$365K Sell
12,215
-12,015
-50% -$348K 0.2% 129
2017
Q3 		$800K Buy
24,230
+12,365
+104% +$428K 0.23% 113
2017
Q2 		$397K Buy
+11,865
New +$354K 0.24% 111

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Curbstone Financial Management Corp's BEAT Position: Q1 2021 in Review

Curbstone Financial Management Corp sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 25,030 shares — an estimated $1.8M sold.

Curbstone Financial Management Corp first reported a position in BEAT in Q2 2017 and held it in 15 quarters. The position peaked at $1.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Curbstone Financial Management Corp reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Curbstone Financial Management Corp sold 25,030 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.8M.
  • Curbstone Financial Management Corp first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 15 quarters.
  • Curbstone Financial Management Corp's BioTelemetry, Inc. position peaked at $1.8M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Curbstone Financial Management Corp's 13F filing for Q1 2021, filed 5 Apr 2021.